🔗 Share this article

A shadow market for unlicensed slimming medications is being driven by TikTok fitness influencers and sellers on communication apps, according to recent findings.

Investigational Treatment Acquiring Popularity Via Social Media

Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its supposed fat-burning effects. Followers are encouraged to contact these accounts privately for source information, while also obtaining discount codes.

Thriving Trade on Social Networks

Separately, a flourishing market exists on Telegram, where communities with thousands of participants share comparison images, injection guides and claims of rapid British shipping. Vendors promote the drug there before directing customers to other platforms for transactions.

Learning About The Experimental Drug

Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could help patients lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.

Healthcare Experts Express Concerns

Nevertheless, doctors and chemists have cautions that the sale of what is still an unapproved drug in the UK is a cause for concern and could lead to users administering products of uncertain source.

Several experts stated the demand for the experimental drug could be connected to the increasing price of approved slimming treatments such as Mounjaro.

Regulatory Status and Implementation

Marketing retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that must not be promoted or supplied for personal consumption under the British medical regulations.

Some content creators try to sidestep the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still violate pharmaceutical, marketing, and customer regulations, risking penalties, prosecution or imprisonment.

Service Response and Content Removal

According to TikTok, the service has removed problematic material and banned related hashtags and search suggestions. The company said it was dedicated to maintaining the service secure and allocating resources in strengthening enforcement strategies.

Digital Marketplace Activities

Investigations also found communities with up to 9,000 members selling retatrutide using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” immediately displays groups with thousands of users, populated with images of weight loss, glowing testimonials and step-by-step instructions for mixing or injecting at home.

Within minutes of joining one community, a seller shared contact information, where most transactions take place. The seller sent an guidebook and promised delivery within 48 hours. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one asked about body mass, medical conditions or previous experience.

Item Details and Pricing

Within these communities, posts display black plastic parcels with Royal Mail labels, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at residence with purified liquid, or pre-filled injectors usually priced at £160 for 20 milligrams. When asked how long a injector should be used, vendors give conflicting responses varying between a several days to “depends on your body”.

Platform Oversight and Safety Measures

A representative for the messaging service said it actively moderated harmful content on its service including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are injecting materials they cannot confirm. Although the research behind this drug is valid, these digital products may not contain what they advertise,” stated Jason Murphy, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the increase in interest to current price rises for authorized slimming drugs such as Mounjaro. “With costs rising, patients are using online platforms. But fake injections are highly risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she said.

Her staff has already seen patients injured by self-injection from unverified suppliers. “We understand the frustration, but buying from messaging apps or WhatsApp is taking chances with your well-being,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”

Producer Position

A spokesperson from Eli Lilly stated the substance was in third stage clinical trials and had not been reviewed or authorized by any government authority globally. “Therefore at this point no one can market [it] for personal consumption,” they said, noting that any item “falsely representing itself as a company experimental product not yet authorized … may expose patients to possibly serious health risks”.